A correlational study on the changes of plasma syndecan-1 of glycocalyx and prognosis in septic treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100055066

Enrollment

Unknown

Registered

2021-12-31

Start date

2022-01-01

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Patients with sepsis.

Exclusion criteria

Exclusion criteria: 1. Unable to obtain informed consent; 2. Pregnant or breastfeeding; 3. Patients with chronic kidney disease stage 4 and above; 4. The patient's sublingual mucosa is damaged or is undergoing mask ventilation, and the sublingual microcirculation image cannot be collected; 5. Transferred to ICU after receiving sepsis-related treatment in other departments.

Design outcomes

Primary

Measure	Time frame
syndecan-1;	—

Countries

China

Contacts

Public ContactCai Changjie

The First Affiliated Hospital of Sun Yat-Sen University

caichjie@mail.sysu.edu.cn+86 135 7009 7848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026